73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Endoscopic approaches feasible in surgery for sinonasal cancer

Endoscopic approaches feasible in surgery for sinonasal cancer

(HealthDay)—Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online Dec. 24 inHead & Neck.Ahmed S. Abdelmeguid, M.D., Ph.D.,

Endoscopic approaches feasible in surgery for sinonasal cancer

(HealthDay)—Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online Dec. 24 inHead & Neck.Ahmed S. Abdelmeguid, M.D., Ph.D.,
Researchers identify path to prevent cognitive decline after radiation

Researchers identify path to prevent cognitive decline after radiation

by Kelsie Smith Hayduk,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at the Del Monte Institute for Neuroscience at the University of Rochester find that mic

Researchers identify path to prevent cognitive decline after radiation

by Kelsie Smith Hayduk,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at the Del Monte Institute for Neuroscience at the University of Rochester find that mic
Exposing cancers to bacteria reminds first responder immune cells which side they're on

Exposing cancers to bacteria reminds first responder immune cells which side they're on

byGarvan InstituteCancer cells (green) being attacked by neutrophils (red) in the collagen structure (blue) of a tumour’s microenvironment. Credit: Jacqueline Bailey / Dr Chtanova's Innate T

Exposing cancers to bacteria reminds first responder immune cells which side they're on

byGarvan InstituteCancer cells (green) being attacked by neutrophils (red) in the collagen structure (blue) of a tumour’s microenvironment. Credit: Jacqueline Bailey / Dr Chtanova's Innate T
Scientists develop new targeted therapeutic strategies to fight liver metastasis

Scientists develop new targeted therapeutic strategies to fight liver metastasis

by Qiu Rong, University of Science and Technology of ChinaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI157937The research group led by Prof. Zeng Zhu

Scientists develop new targeted therapeutic strategies to fight liver metastasis

by Qiu Rong, University of Science and Technology of ChinaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI157937The research group led by Prof. Zeng Zhu
MRD Could Play Role in Predicting Post-ASCT Outcomes in Myeloma

MRD Could Play Role in Predicting Post-ASCT Outcomes in Myeloma

September 9, 2021Darlene Dobkowski, MAFor patients with myeloma have undergone an autologous stem cell transplant and are currently on maintenance therapy with lenalidomide, minimal residual disease m

MRD Could Play Role in Predicting Post-ASCT Outcomes in Myeloma

September 9, 2021Darlene Dobkowski, MAFor patients with myeloma have undergone an autologous stem cell transplant and are currently on maintenance therapy with lenalidomide, minimal residual disease m
For first time in 40 years, cure for acute leukemia within reach

For first time in 40 years, cure for acute leukemia within reach

by Tali Aronsky,Hebrew University of JerusalemBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaAcute myeloid leukemia is one of the most aggre

For first time in 40 years, cure for acute leukemia within reach

by Tali Aronsky,Hebrew University of JerusalemBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaAcute myeloid leukemia is one of the most aggre
Scientists find new marker that predicts early recurrence of breast cancer

Scientists find new marker that predicts early recurrence of breast cancer

byMedical College of WisconsinPD-L2 immunostaining in ER+ breast cancer. (A-C; brown signal) Immunohistochemistry of PD-L2 using diaminobenzidine chromogen and (D-F; red signal) immunofluorescen

Scientists find new marker that predicts early recurrence of breast cancer

byMedical College of WisconsinPD-L2 immunostaining in ER+ breast cancer. (A-C; brown signal) Immunohistochemistry of PD-L2 using diaminobenzidine chromogen and (D-F; red signal) immunofluorescen
Researchers test previously approved FDA drugs to treat Lowe syndrome

Researchers test previously approved FDA drugs to treat Lowe syndrome

by Purdue UniversityR. Claudio Aguilar, a Purdue University researcher, has developed a patented therapeutic strategy for Lowe syndrome by repurposing two drugs previously approved by the U.S. Fo

Researchers test previously approved FDA drugs to treat Lowe syndrome

by Purdue UniversityR. Claudio Aguilar, a Purdue University researcher, has developed a patented therapeutic strategy for Lowe syndrome by repurposing two drugs previously approved by the U.S. Fo
Pancreatic cancer cells secrete signal that sabotages immune attack on tumors

Pancreatic cancer cells secrete signal that sabotages immune attack on tumors

byNYU Langone HealthMouse pancreatic tumor cells (red) produce the signaling protein IL-1β (green) to support cancer growth by suppressing the immune system. Credit: NYU Grossman School of Medic

Pancreatic cancer cells secrete signal that sabotages immune attack on tumors

byNYU Langone HealthMouse pancreatic tumor cells (red) produce the signaling protein IL-1β (green) to support cancer growth by suppressing the immune system. Credit: NYU Grossman School of Medic
Routine HPV testing may be warranted for sinonasal cancers

Routine HPV testing may be warranted for sinonasal cancers

(HealthDay)—Only one in four patients with sinonasal squamous cell carcinoma (SNSCC) is tested for human papillomavirus (HPV), according to a study published online Dec. 30 inCancer.Jamie R. Oli

Routine HPV testing may be warranted for sinonasal cancers

(HealthDay)—Only one in four patients with sinonasal squamous cell carcinoma (SNSCC) is tested for human papillomavirus (HPV), according to a study published online Dec. 30 inCancer.Jamie R. Oli
Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

byCell PressCredit: Pixabay/CC0 Public DomainHigh tumor mutational burden—the number of mutations found inside cancer cells—may not generalize as an accurate biomarker across diverse cancer pati

Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

byCell PressCredit: Pixabay/CC0 Public DomainHigh tumor mutational burden—the number of mutations found inside cancer cells—may not generalize as an accurate biomarker across diverse cancer pati